Metformin Affects Cardiac Arachidonic Acid Metabolism and Cardiac Lipid Metabolite Storage in a Prediabetic Rat Model

Metformin can reduce cardiovascular risk independent of glycemic control. The mechanisms behind its non-glycemic benefits, which include decreased energy intake, lower blood pressure and improved lipid and fatty acid metabolism, are not fully understood. In our study, metformin treatment reduced myo...

Descripción completa

Detalles Bibliográficos
Autores principales: Miklankova, Denisa, Markova, Irena, Hüttl, Martina, Zapletalova, Iveta, Poruba, Martin, Malinska, Hana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305829/
https://www.ncbi.nlm.nih.gov/pubmed/34299301
http://dx.doi.org/10.3390/ijms22147680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8305829/
https://www.ncbi.nlm.nih.gov/pubmed/34299301
http://dx.doi.org/10.3390/ijms22147680

Ejemplares similares